Skip to main content

Dapagliflozin

NDC 70954-856 · ANI Pharmaceuticals, Inc.

Generic nameDapagliflozin
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)DAPAGLIFLOZIN
Strength5 mg/1
Pharmacologic classSodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

70954-856-10 — 30 TABLET, FILM COATED in 1 BOTTLE (70954-856-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70710-1380 — Dapagliflozin, 70710-1381 — Dapagliflozin, 70748-101 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-102 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-103 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-104 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-105 — Dapagliflozin, 70748-106 — Dapagliflozin, 70771-1714 — Dapagliflozin, 70771-1715 — Dapagliflozin, 70954-857 — Dapagliflozin, 71921-420 — Dapagliflozin, 71921-421 — Dapagliflozin, 72205-432 — Dapagliflozin, 72205-433 — Dapagliflozin, 72205-434 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 72205-435 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 72205-436 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 72205-437 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 72205-438 — DAPAGLIFLOZIN AND SAXAGLIPTIN, +40 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels